Contact the Editorial Desk

Editorial correspondence

Lazarus Research Peptides welcomes correspondence on the research record: a citation quoted inaccurately, a regulatory reference that has gone out of date, or a peer-reviewed study on Thymosin Alpha-1, Thymulin, or KPV that should be added to the references page. Corrections that improve the accuracy of the digest are the most useful messages this desk receives.

The most actionable notes specify three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible. That lets us verify a proposed change against the source quickly.

Editorial mailbox: editors@lazarusresearchpeptides.com

What this desk cannot do

A few things fall outside what this site can address. Lazarus Research Peptides is a literature digest, not a clinic or vendor, so we cannot:

• Advise on, recommend, or comment on human use of any peptide discussed here.
• Suggest a dose, schedule, or route of administration for any individual.
• Diagnose a condition or evaluate whether a research finding applies to a specific person.
• Sell, source, recommend, or help locate any compound from any supplier.
• Answer requests from athletes subject to anti-doping rules about unapproved peptides.

Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently.